J Ribes1, R Clèries, M Buxó, A Ameijide, J Valls, R Gispert. 1. Registre de Càncer de Catalunya, Pla Director d'Oncologia, Departament de Salut, Generalitat de Catalunya, Barcelona, España. j.ribes@iconcologia.net
Abstract
BACKGROUND AND OBJECTIVE: To perform cancer incidence and mortality projections in Catalonia for the period 2005-2019. To assess the projected increase in the incidence in 2015 compared with that in 2005, and to determine whether this increase is attributable to changes in risk or in demographics. POPULATION AND METHOD: Bayesian age-period-cohort models were fitted to age-specific rates for 1985-2004 to obtain the expected number of cases for the 5-year periods 2005-2009, 2010-2014 and 2015- 2019. Annual cases were estimated through a polynomial interpolation model. Incidence and mortality data were obtained from the Tarrragona and Gerona cancer registries, while population pyramids for the period 1985-2019 were obtained from the Catalan Institute of Statistics. RESULTS: In Catalonia, 27,438 cancer cases will be diagnosed among men and 19,986 among women in 2015, representing an increase in the number of cases diagnosed of 31% and 34%, respectively, when compared with those diagnosed in 2005 (20,999 and 14,141, respectively). In men, the increases attributable to risk, aging and demographic changes are 10%, 14% and 7%, respectively, whereas in women these changes are 6%, 13% and 15%. In the next decade, cancer mortality is expected to stabilize in men and to continue to decrease in women. Major increases in cancer incidence and mortality are expected among old age groups. CONCLUSIONS: The present study highlights the need to reorganize the resources and infrastructures required for cancer control and care, taking into account the predicted burden of oncology patients.
BACKGROUND AND OBJECTIVE: To perform cancer incidence and mortality projections in Catalonia for the period 2005-2019. To assess the projected increase in the incidence in 2015 compared with that in 2005, and to determine whether this increase is attributable to changes in risk or in demographics. POPULATION AND METHOD: Bayesian age-period-cohort models were fitted to age-specific rates for 1985-2004 to obtain the expected number of cases for the 5-year periods 2005-2009, 2010-2014 and 2015- 2019. Annual cases were estimated through a polynomial interpolation model. Incidence and mortality data were obtained from the Tarrragona and Gerona cancer registries, while population pyramids for the period 1985-2019 were obtained from the Catalan Institute of Statistics. RESULTS: In Catalonia, 27,438 cancer cases will be diagnosed among men and 19,986 among women in 2015, representing an increase in the number of cases diagnosed of 31% and 34%, respectively, when compared with those diagnosed in 2005 (20,999 and 14,141, respectively). In men, the increases attributable to risk, aging and demographic changes are 10%, 14% and 7%, respectively, whereas in women these changes are 6%, 13% and 15%. In the next decade, cancer mortality is expected to stabilize in men and to continue to decrease in women. Major increases in cancer incidence and mortality are expected among old age groups. CONCLUSIONS: The present study highlights the need to reorganize the resources and infrastructures required for cancer control and care, taking into account the predicted burden of oncology patients.
Authors: Susana Puig; Joaquim Marcoval; Cristina Paradelo; Antoni Azon; Ramon Bartralot; Susana Bel; Xavier Bigata; Aram Boada; Antoni Campoy; Cristina Carrera; Neus Curco; Joan Dalmau; Carlos Ferrándiz; Josep R Ferreres; Manel Formigon; Fernando Gallardo; Alberto Gonzalez; Miquel Just; Enric Llistosella; Rosa M Marti; M Elena Nogues; Ramon Pedragosa; Josep A Pujol; Rodrigo Roldán-Marín; Mireia Sabat; Montserrat Salleras; Juan A Smandia; Pedro Zaballos; Estel Plana; Josep Malvehy Journal: Acta Derm Venereol Date: 2015-04 Impact factor: 4.437
Authors: Joan Valls; Ramon Clèries; Jordi Gálvez; Victor Moreno; Rosa Gispert; Josep M Borràs; Josepa Ribes Journal: BMC Public Health Date: 2009-12-18 Impact factor: 3.295
Authors: R Clèries; L Esteban; J Borràs; R Marcos-Gragera; A Freitas; M Carulla; M Buxó; A Puigdefàbregas; A Izquierdo; R Gispert; J Galceran; J Ribes Journal: Clin Transl Oncol Date: 2013-06-06 Impact factor: 3.405